Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
NCT05944133 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 27257
Last updated 2024-10-17
Summary
The goal of this multi-site observational cohort study is to link electronic health records (EHR) with novel data sources to examine insurance instability and its association with all-cause and overdose mortality in adult patients who received medications for opioid use disorder (MOUD). The main objectives of the study are:
* Objective 1. Perform data linkage of a cohort of patients who received MOUD with the National Death Index using a probabilistic algorithm for matching records to ascertain fact and cause of death relative to treatment and insurance status.
* Objective 2: Assess the association of insurance instability and risk of death, including all-cause mortality and drug- and alcohol-related overdose mortality.
Conditions
Interventions
- OTHER
-
No intervention, observational retrospective study
No intervention
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Kaiser Permanente
lead OTHER
Principal Investigators
-
Anh P Nguyen, PhD · Kaiser Permanente
-
Ingrid A Binswanger, MD · Kaiser Permanente
-
Jason M Glanz, PhD · Kaiser Permanente
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-29
- Primary Completion
- 2025-02-28
- Completion
- 2026-02-28
Countries
- United States
Study Locations
More Related Trials
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
NCT05988710 ·Status: RECRUITING ·Phase: PHASE4
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
NCT05307458 ·Status: UNKNOWN
-
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
NCT05336188 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000239 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
NCT04815590 ·Status: UNKNOWN
-
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
NCT02559973 ·Status: COMPLETED ·Phase: PHASE1
-
Extended-release Pharmacotherapy for Opioid Use Disorder
NCT05164549 ·Status: COMPLETED ·Phase: PHASE3
-
Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder
NCT05594121 ·Status: UNKNOWN ·Phase: PHASE4
-
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
NCT01559454 ·Status: COMPLETED ·Phase: PHASE4
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
NCT01967641 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Dose Alteration Study - 1
NCT00000219 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
NCT02751762 ·Status: COMPLETED
-
Alternate-Day Buprenorphine Administration. Phase I - 3
NCT00000221 ·Status: COMPLETED ·Phase: PHASE1
-
Sublingual Buprenorphine for Chronic Pain
NCT00612287 ·Status: UNKNOWN ·Phase: PHASE2
-
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
NCT01136356 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Abuse Potential of Buprenorphine/Naloxone
NCT00149539 ·Status: TERMINATED ·Phase: PHASE2
-
Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000357 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
NCT02224508 ·Status: COMPLETED